Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance

Chuanlin Ding,Yunfeng Ma,Xingguo Chen,Min Liu,Yihua Cai,Xiaoling Hu,Dong Xiang,Swapan Nath,Huang-ge Zhang,Hong Ye,David Powell,Jun Yan
DOI: https://doi.org/10.1038/ncomms3813
IF: 16.6
2013-11-22
Nature Communications
Abstract:A variant of the integrin-α-M (CD11b) gene has been linked to the pathogenesis of systemic lupus erythematosus. However, how this genotype results in the lupus phenotype is not fully understood. Here we show that autoreactive B cells lacking CD11b exhibit a hyperproliferative response to B cell receptor (BCR) crosslinking and enhanced survival. In vivo engagement of BCR in CD11b-deficient mice leads to increased autoAb production and kidney Ig deposition. In addition, CD11b-deficient autoreactive B cells have decreased tyrosine phosphorylation including Lyn and CD22 with decreased phosphatase SHP-1 recruitment but increased calcium influx. Results obtained using B cells transfected with the wild type or rs1143679 lupus-associated variant of CD11b suggest that this mutation completely abrogates the regulatory effect of CD11b on BCR signalling. This is through disruption of CD22–CD11b direct binding. These results reveal a previously unrecognized role of CD11b in maintaining autoreactive B cell tolerance.
multidisciplinary sciences
What problem does this paper attempt to address?